Clínic Barcelona
Clínic Barcelona
Research
June 12 2025
News about CIBERONC
- Jan (21)
- Feb (19)
- Mar (23)
- Apr (22)
- May (22)
- Jun (20)
- Jul (27)
- Aug (10)
- Sep (24)
- Oct (24)
- Nov (34)
- Dec (20)
- Jan (24)
- Feb (27)
- Mar (15)
- Apr (23)
- May (34)
- Jun (28)
- Jul (26)
- Aug (11)
- Sep (19)
- Oct (20)
- Nov (28)
- Dec (14)
- Jan (14)
- Feb (22)
- Mar (21)
- Apr (12)
- May (20)
- Jun (23)
- Jul (20)
- Aug (5)
- Sep (19)
- Oct (19)
- Nov (26)
- Dec (15)
- Jan (4)
- Feb (18)
- Mar (13)
- Apr (15)
- May (19)
- Jun (22)
- Jul (18)
- Aug (9)
- Sep (11)
- Oct (25)
- Nov (19)
- Dec (15)
- Jan (12)
- Feb (6)
- Mar (13)
- Apr (5)
- May (7)
- Jun (15)
- Jul (11)
- Aug (3)
- Sep (5)
- Oct (8)
- Nov (15)
- Dec (13)
Clínic Barcelona
Clínic Barcelona
Research
June 20 2024
A new 3D model is developed to simulate the tumour microenvironment of a type of lymphoma
Researchers at the Clínic-IDIBAPS coordinated a study published in Blood Cancer Journal in which a new 3D system was developed from patient samples t1
Clínic Barcelona
Clínic Barcelona
Research
March 28 2024
The European THERAVLINFO project led by IDIBAPS-Hospital Clínic Barcelona is launched to advance personalised lymphoma medicine
The project led by Patricia Pérez Galán, the head of IDIBAPS’ Microenvironment in lymphoma pathogenesis and therapy research group, is the continuati1
Clínic Barcelona
Clínic Barcelona
Research
October 5 2022
Leukaemia’s evolution is already written right from the start, at the time of diagnosis
This discovery changes the view of the progression of leukaemia, opens the door to early diagnosis, and offers new treatment strategies.
Clínic Barcelona
Clínic Barcelona
Research
February 17 2022
A new treatment without chemotherapy for indolent clinical forms of mantle cell lymphoma
A study led by researchers from the Hospital Clínic-IDIBAPS shows that a new treatment without chemotherapy is effective in treating indolent clinica1
Clínic Barcelona
Clínic Barcelona
Research
April 19 2021
The interaction between follicular lymphoma and its microenvironment reveals a new therapeutic strategy
Researchers from IDIBAPS and CIBERONC have analysed the interaction between follicular lymphoma and its tumour microenvironment and propose a new pro1
Clínic Barcelona
Clínic Barcelona
Research
February 12 2021
Sílvia Beà, winner of the CIBERONC “Award for Best Female Researcher”
Beà, a researcher of the IDIBAPS group Molecular pathology in lymphoid neoplasms, has authored 119 articles, 30 of them as the principal author, with1